Jérôme Fayette

Head and Neck Cancer Studies (174) Cancer Immunotherapy and Biomarkers (132) Lung Cancer Treatments and Mutations (112) Lung Cancer Research Studies (41) Cancer Diagnosis and Treatment (38)

Affiliations

Université Claude Bernard Lyon 1

FR 2025 - 2007

Leiden University

NL 1997 - 1997

Centre National de la Recherche Scientifique

FR 2022 - 2021

Amgen (United States)

US 2021 - 2021

Inserm

FR 2023 - 2005

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers

Jérôme Fayette

Publication & Citation Trends

Publications

Abstract 735: Immunologically active phenotype by gene expression profiling predicts clinical benefit from PD-1/PD-L1 inhibitors in a pancancer cohort

Uncovering immune checkpoint heterogeneity in oral squamous cell carcinoma using single cell RNA-sequencing data highlights three subgroups of patients with distinct immune phenotypes.

Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma OA

147P Non-small cell lung cancer: Artificial intelligence enables the identification of survival signatures complementary to an Immunologically active gene expression signature involving previous therapies OA

Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer OA

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back